DXC Technology Co (DXC) stock

DXCNYSEServices-Computer Processing & Data PreparationFiscal year ends March 31

Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026Score 10/3084% below fair value

$14.98−0.25 (-1.64%)

Close on Oct 30, 2026Market cap $2.39BP/E 20.5Yield –

Earnings

DXC Technology's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report

Jan 28, 2027

Q3 FY2027 · estimated, during market hours

Revenue, Q2 FY2027

$3.03B

-4.1% on a year earlier

Non-GAAP diluted earnings per share, Q2 FY2027

$0.67

$0.84 a year earlier

Latest guidance

Issued

Oct 29, 2026 · 7 items

Quarterly results

Revenue and earnings per share from each of DXC Technology's earnings releases, newest first

Quarter	Reported	Revenue	YoY	EPS	Adj. EPS	Source
Q3 FY2027ended Dec 31, 2026	Jan 28, 2027Expected	–	–	–	–	–
Q2 FY2027ended Sep 30, 2026	Oct 29, 2026after the close	$3.03B	-4.1%	$0.15	$0.67	Release
Q1 FY2027ended Jun 30, 2026	Jul 30, 2026during market hours	$3.00B	-5.1%	$0.73	$0.40	Release
Q4 FY2026ended Mar 31, 2026	May 7, 2026during market hours	$3.13B	-1.3%	-$0.84	$0.77	Release
Q3 FY2026ended Dec 31, 2025	Jan 29, 2026during market hours	$3.19B	-1.2%	$0.61	$0.96	Release
Q2 FY2026ended Sep 30, 2025	Oct 30, 2025during market hours	$3.16B	-2.5%	$0.20	$0.84	Release
Q1 FY2026ended Jun 30, 2025	Jul 31, 2025during market hours	$3.16B	-2.5%	$0.09	$0.68	Release
Q4 FY2025ended Mar 31, 2025	May 14, 2025during market hours	$3.17B	-6.5%	$1.43	$0.84	Release
Q3 FY2025ended Dec 31, 2024	Feb 4, 2025during market hours	$3.23B	-5.0%	$0.31	$0.92	Release
Q2 FY2025ended Sep 30, 2024	Nov 7, 2024during market hours	$3.24B	-5.8%	$0.23	$0.93	Release
Q1 FY2025ended Jun 30, 2024	Aug 8, 2024during market hours	$3.24B	-6.1%	$0.14	$0.74	Release
Q4 FY2024ended Mar 31, 2024	May 16, 2024during market hours	$3.39B	-5.6%	-$1.10	$0.97	Release
Q3 FY2024ended Dec 31, 2023	Feb 1, 2024during market hours	$3.40B	-4.8%	$0.81	$0.87	Release
Q2 FY2024ended Sep 30, 2023	Nov 1, 2023during market hours	$3.44B	-3.6%	$0.49	$0.70	Release
Q1 FY2024ended Jun 30, 2023	Aug 2, 2023during market hours	$3.45B	-7.0%	$0.17	$0.63	Release
Q4 FY2023ended Mar 31, 2023	May 18, 2023during market hours	$3.59B	-10.5%	-$3.38	$1.02	Release
Q3 FY2023ended Dec 31, 2022	Feb 1, 2023during market hours	$3.57B	-12.7%	$0.25	$0.95	Release
Q2 FY2023ended Sep 30, 2022	Nov 3, 2022during market hours	$3.57B	-11.4%	$0.12	$0.75	Release
Q1 FY2023ended Jun 30, 2022	Aug 3, 2022during market hours	$3.71B	–	$0.43	$0.75	Release
Q4 FY2022ended Mar 31, 2022	May 25, 2022during market hours	$4.01B	–	$2.14	$0.84	Release
Q3 FY2022ended Dec 31, 2021	Feb 2, 2022during market hours	$4.09B	–	$0.38	$0.92	Release
Q2 FY2022ended Sep 30, 2021	Nov 3, 2021during market hours	$4.03B	–	-$0.74	$0.90	Release
Q1 FY2022ended Jun 30, 2021	Aug 4, 2021during market hours	–	–	–	–	Filing
Q4 FY2021ended Mar 31, 2021	May 26, 2021during market hours	–	–	–	–	Filing
Q3 FY2021ended Dec 31, 2020	Feb 4, 2021during market hours	–	–	–	–	Filing
Q2 FY2021ended Sep 30, 2020	Nov 5, 2020during market hours	–	–	–	–	Filing

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

DXC Technology's latest outlook for periods it has not reported yet, compared with what it said before

Metric	Period	Guidance	Before	Change	Given
Total revenueGAAP	Q3 FY2027	$2.98B	–	New	Oct 29, 2026
Adjusted EBIT marginnon-GAAP	Q3 FY2027	6%	–	New	Oct 29, 2026
Non-GAAP Diluted EPSnon-GAAP	Q3 FY2027	$0.55	–	New	Oct 29, 2026
revenue year-over-year on an organic basisnon-GAAP	FY2027	-5% – -3%	-5% – -3%	Reaffirmed	Jul 30, 2026
Total revenueGAAP	FY2027	$11.91B – $11.98B	–	New	Oct 29, 2026
Total revenue	FY2027	$12.10B – $12.35B	$12.11B – $12.35B	Lowered	Jul 30, 2026
Adjusted EBIT marginnon-GAAP	FY2027	5.75% – 6.25%	–	New	Oct 29, 2026
Adjusted EBIT marginnon-GAAP	FY2027	6% – 7%	6% – 7%	Reaffirmed	Jul 30, 2026
Non-GAAP diluted EPSnon-GAAP	FY2027	$2.25 – $2.50	–	New	Oct 29, 2026
Non-GAAP diluted EPSnon-GAAP	FY2027	$2.40 – $2.90	$2.40 – $2.90	Reaffirmed	Jul 30, 2026
Free Cash Flownon-GAAP	FY2027	$600.00M	–	New	Oct 29, 2026
Free Cash Flownon-GAAP	FY2027	$685.00M	$600.00M	Raised	Jul 30, 2026

Guidance vs results

The last range DXC Technology gave before each report, against the figure it then reported. Full years add up the four quarters.

Period	Metric	Guidance	Actual	Result
Q2 FY2027	Non-GAAP Diluted EPS	$0.55	$0.67	Above range
Q2 FY2027	Revenue	$2.97B – $3.00B	$3.03B	Above range
Q1 FY2027	Non-GAAP Diluted EPS	$0.40	$0.40	Within range
Q1 FY2027	Revenue	$2.97B – $3.00B	$3.00B	Within range
FY2026	Non-GAAP diluted EPS	$3.15	$3.25Σ4Q	Above range
FY2026	Revenue	$12.69B	$12.64BΣ4Q	Below range
Q4 FY2026	Non-GAAP Diluted EPS	$0.65 – $0.75	$0.77	Above range
Q4 FY2026	Revenue	$3.16B – $3.19B	$3.13B	Below range
Q3 FY2026	Non-GAAP Diluted EPS	$0.75 – $0.85	$0.96	Above range
Q3 FY2026	Revenue	$3.18B – $3.22B	$3.19B	Within range
Q2 FY2026	Non-GAAP Diluted EPS	$0.65 – $0.75	$0.84	Above range
Q2 FY2026	Revenue	$3.15B – $3.18B	$3.16B	Within range
Q1 FY2026	Non-GAAP Diluted EPS	$0.55 – $0.65	$0.68	Above range
Q1 FY2026	Revenue	$3.04B – $3.09B	$3.16B	Above range
FY2025	Non-GAAP diluted EPS	$3.35	$3.43Σ4Q	Above range
FY2025	Revenue	$12.80B – $12.83B	$12.88BΣ4Q	Above range
Q4 FY2025	Non-GAAP Diluted EPS	$0.75	$0.84	Above range
Q4 FY2025	Revenue	$3.10B – $3.13B	$3.17B	Above range
Q3 FY2025	Non-GAAP Diluted EPS	$0.75 – $0.80	$0.92	Above range
Q3 FY2025	Revenue	$3.20B – $3.30B	$3.23B	Within range
Q2 FY2025	Non-GAAP Diluted EPS	$0.70 – $0.75	$0.93	Above range
Q2 FY2025	Revenue	$3.19B – $3.22B	$3.24B	Above range
Q1 FY2025	Non-GAAP Diluted EPS	$0.55 – $0.60	$0.74	Above range
Q1 FY2025	Revenue	$3.10B – $3.15B	$3.24B	Above range
Q4 FY2024	Non-GAAP Diluted EPS	$0.80 – $0.85	$0.97	Above range
Q4 FY2024	Revenue	$3.35B – $3.39B	$3.39B	Within range
Q3 FY2024	Non-GAAP Diluted EPS	$0.75 – $0.80	$0.87	Above range
Q3 FY2024	Revenue	$3.32B – $3.37B	$3.40B	Above range
Q2 FY2024	Non-GAAP Diluted EPS	$0.65 – $0.70	$0.70	Within range
Q2 FY2024	Revenue	$3.43B – $3.46B	$3.44B	Within range
Q1 FY2024	Non-GAAP Diluted EPS	$0.80 – $0.85	$0.63	Below range
Q1 FY2024	Revenue	$3.54B – $3.58B	$3.45B	Below range
Q4 FY2023	Non-GAAP Diluted EPS	$1.00 – $1.05	$1.02	Within range
Q4 FY2023	Revenue	$3.62B – $3.64B	$3.59B	Below range
Q3 FY2023	Non-GAAP Diluted EPS	$0.80 – $0.85	$0.95	Above range
Q3 FY2023	Revenue	$3.55B – $3.58B	$3.57B	Within range
Q2 FY2023	Non-GAAP Diluted EPS	$0.70 – $0.75	$0.75	Within range
Q2 FY2023	Revenue	$3.55B – $3.58B	$3.57B	Within range
Q1 FY2023	Non-GAAP Diluted EPS	$0.80 – $0.85	$0.75	Below range
Q1 FY2023	Revenue	$3.70B – $3.75B	$3.71B	Within range
Q4 FY2022	Non-GAAP Diluted EPS	$0.98 – $1.03	$0.84	Below range
Q4 FY2022	Revenue	$4.11B – $4.15B	$4.01B	Below range
Q3 FY2022	Non-GAAP Diluted EPS	$0.88 – $0.93	$0.92	Within range
Q3 FY2022	Revenue	$4.08B – $4.13B	$4.09B	Within range

Guidance history

Every forecast DXC Technology put in an earnings release, newest first

Given	Metric	Period	Guidance	Change
Oct 29, 2026	Non-GAAP Diluted EPS	Q3 FY2027	$0.55	New
Oct 29, 2026	Non-GAAP diluted EPS	FY2027	$2.25 – $2.50	New
Oct 29, 2026	Free Cash Flow	FY2027	$600.00M	New
Oct 29, 2026	Adjusted EBIT margin	Q3 FY2027	6%	New
Oct 29, 2026	Adjusted EBIT margin	FY2027	5.75% – 6.25%	New
Oct 29, 2026	Total revenue	FY2027	$11.91B – $11.98B	New
Oct 29, 2026	Total revenue	Q3 FY2027	$2.98B	New
Jul 30, 2026	Non-GAAP diluted EPS	FY2027	$2.40 – $2.90	Reaffirmed
Jul 30, 2026	Non-GAAP Diluted EPS	Q2 FY2027	$0.55	New
Jul 30, 2026	Free Cash Flow	FY2027	$685.00M	Raised
Jul 30, 2026	Adjusted EBIT margin	FY2027	6% – 7%	Reaffirmed
Jul 30, 2026	Adjusted EBIT margin	Q2 FY2027	6%	New
Jul 30, 2026	revenue year-over-year on an organic basis	FY2027	-5% – -3%	Reaffirmed
Jul 30, 2026	Total revenue	FY2027	$12.10B – $12.35B	Lowered
Jul 30, 2026	revenue year-over-year on an organic basis	Q2 FY2027	-6.5% – -5.5%	New
Jul 30, 2026	Total revenue	Q2 FY2027	$2.97B – $3.00B	New
May 7, 2026	Non-GAAP diluted EPS	FY2027	$2.40 – $2.90	New
May 7, 2026	Non-GAAP Diluted EPS	Q1 FY2027	$0.40	New
May 7, 2026	Free Cash Flow	FY2027	$600.00M	New
May 7, 2026	Adjusted EBIT margin	FY2027	6% – 7%	New
May 7, 2026	Adjusted EBIT margin	Q1 FY2027	5%	New
May 7, 2026	YoY Organic Revenue %	FY2027	-5% – -3%	New
May 7, 2026	Total revenue	FY2027	$12.11B – $12.35B	New
May 7, 2026	YoY Organic Revenue %	Q1 FY2027	-7.5% – -6.5%	New
May 7, 2026	Total revenue	Q1 FY2027	$2.97B – $3.00B	New
Jan 29, 2026	Non-GAAP diluted EPS	FY2026	$3.15	Narrowed
Jan 29, 2026	Non-GAAP Diluted EPS	Q4 FY2026	$0.65 – $0.75	New
Jan 29, 2026	Free Cash Flow	FY2026	$650.00M	Reaffirmed
Jan 29, 2026	Adjusted EBIT margin	FY2026	7.5%	Narrowed
Jan 29, 2026	Adjusted EBIT margin	Q4 FY2026	6.5% – 7.5%	New
Jan 29, 2026	Non-GAAP Tax Rate	FY2026	37%	Raised
Jan 29, 2026	Non-GAAP Net Interest Expense ($M)	FY2026	$37.00M	Lowered
Jan 29, 2026	Non-GAAP Tax Rate	Q4 FY2026	40%	New
Jan 29, 2026	Non-GAAP Net Interest Expense ($M)	Q4 FY2026	$16.00M	New
Jan 29, 2026	organic basis	FY2026	-4.3%	Narrowed
Jan 29, 2026	Total revenue	FY2026	$12.69B	Narrowed
Jan 29, 2026	YoY Organic Revenue %	Q4 FY2026	-5% – -4%	New
Jan 29, 2026	Total revenue	Q4 FY2026	$3.16B – $3.19B	New
Oct 30, 2025	Non-GAAP diluted EPS	FY2026	$2.85 – $3.35	Reaffirmed
Oct 30, 2025	Non-GAAP Diluted EPS	Q3 FY2026	$0.75 – $0.85	New
Oct 30, 2025	Free Cash Flow	FY2026	$650.00M	Raised
Oct 30, 2025	Adjusted EBIT margin	FY2026	7% – 8%	Reaffirmed
Oct 30, 2025	Adjusted EBIT margin	Q3 FY2026	7% – 8%	New
Oct 30, 2025	Total revenue ... on an organic basis	FY2026	-4.5% – -3.5%	Narrowed
Oct 30, 2025	Total revenue	FY2026	$12.67B – $12.81B	Narrowed
Oct 30, 2025	Total revenue ... on an organic basis	Q3 FY2026	-5% – -4%	New
Oct 30, 2025	Total revenue	Q3 FY2026	$3.18B – $3.22B	New
Jul 31, 2025	Non-GAAP diluted EPS	FY2026	$2.85 – $3.35	Raised
Jul 31, 2025	Non-GAAP Diluted EPS	Q2 FY2026	$0.65 – $0.75	New
Jul 31, 2025	Free Cash Flow	FY2026	$600.00M	Reaffirmed
Jul 31, 2025	Adjusted EBIT margin	FY2026	7% – 8%	Reaffirmed
Jul 31, 2025	Adjusted EBIT margin	Q2 FY2026	6.5% – 7.5%	New
Jul 31, 2025	Non-GAAP Tax Rate	FY2026	35%	Reaffirmed
Jul 31, 2025	Net Interest Expense ($M)	FY2026	$60.00M	New
Jul 31, 2025	Non-GAAP Tax Rate	Q2 FY2026	40%	New
Jul 31, 2025	Net Interest Expense ($M)	Q2 FY2026	$12.00M	New
Jul 31, 2025	Total revenue year-over-year on an organic basis	FY2026	-5% – -3%	New
Jul 31, 2025	Total revenue	FY2026	$12.61B – $12.87B	Raised
Jul 31, 2025	Total revenue year-over-year on an organic basis	Q2 FY2026	-4.5% – -3.5%	New
Jul 31, 2025	Total revenue	Q2 FY2026	$3.15B – $3.18B	New
May 14, 2025	Non-GAAP diluted EPS	FY2026	$2.75 – $3.25	New
May 14, 2025	Non-GAAP Diluted EPS	Q1 FY2026	$0.55 – $0.65	New
May 14, 2025	Free Cash Flow	FY2026	$600.00M	New
May 14, 2025	Adjusted EBIT margin	FY2026	7% – 8%	New
May 14, 2025	Adjusted EBIT margin	Q1 FY2026	6% – 7%	New
May 14, 2025	Non-GAAP Tax Rate	FY2026	35%	New
May 14, 2025	Net Interest Expense ($M)	FY2026	$60.00M	New
May 14, 2025	Non-GAAP Tax Rate	Q1 FY2026	40%	New
May 14, 2025	Net Interest Expense ($M)	Q1 FY2026	$15.00M	New
May 14, 2025	Total revenue	FY2026	$12.18B – $12.44B	New
May 14, 2025	Total revenue	Q1 FY2026	$3.04B – $3.09B	New
Feb 4, 2025	Capital Lease / Asset Financing Payments	FY2025	$290.00M	New
Feb 4, 2025	Non-GAAP diluted EPS	FY2025	$3.35	New
Feb 4, 2025	Non-GAAP Diluted EPS	Q4 FY2025	$0.75	New
Feb 4, 2025	Free Cash Flow	FY2025	$625.00M	New
Feb 4, 2025	Adjusted EBIT margin	FY2025	7.9%	New
Feb 4, 2025	Adjusted EBIT margin	Q4 FY2025	7%	New
Feb 4, 2025	Weighted Average Diluted Shares Outstanding	FY2025	184	New
Feb 4, 2025	Non-GAAP Tax Rate	FY2025	33%	New
Feb 4, 2025	Pension Income Benefit*	FY2025	$108.00M	New
Feb 4, 2025	Net Interest Expense	FY2025	$70.00M	Lowered
Feb 4, 2025	Restructuring & TSI Expense	FY2025	$200.00M	Raised
Feb 4, 2025	Weighted Average Diluted Shares Outstanding	Q4 FY2025	185	New
Feb 4, 2025	Non-GAAP Tax Rate	Q4 FY2025	29%	New
Feb 4, 2025	Pension Income Benefit*	Q4 FY2025	$27.00M	New
Feb 4, 2025	Net Interest Expense	Q4 FY2025	$15.00M	Lowered
Feb 4, 2025	organic basis decline	FY2025	-4.9% – -4.7%	New
Feb 4, 2025	Total revenue	FY2025	$12.80B – $12.83B	New
Feb 4, 2025	decline year-over-year on an organic basis	Q4 FY2025	-5.5% – -4.5%	New
Feb 4, 2025	Total revenue	Q4 FY2025	$3.10B – $3.13B	New
Nov 7, 2024	Non-GAAP Diluted EPS	Q3 FY2025	$0.75 – $0.80	New
Nov 7, 2024	Non-GAAP diluted EPS	FY2025	$3.00 – $3.25	Raised
Nov 7, 2024	Free Cash Flow	FY2025	$550.00M	Raised
Nov 7, 2024	Adjusted EBIT margin	Q3 FY2025	7% – 7.5%	New
Nov 7, 2024	Adjusted EBIT margin	FY2025	7% – 7.5%	Raised
Nov 7, 2024	Total revenue on an organic basis	Q3 FY2025	-5.5% – -4.5%	New
Nov 7, 2024	Total revenue	Q3 FY2025	$3.20B – $3.30B	New
Nov 7, 2024	Total revenue on an organic basis	FY2025	-5.5% – -4.5%	Narrowed
Nov 7, 2024	Total revenue	FY2025	$12.90B – $13.10B	Raised
Aug 8, 2024	Non-GAAP Diluted EPS	Q2 FY2025	$0.70 – $0.75	New
Aug 8, 2024	Non-GAAP diluted EPS	FY2025	$2.75 – $3.00	Raised
Aug 8, 2024	Free Cash Flow	FY2025	$450.00M	Raised
Aug 8, 2024	Adjusted EBIT margin	Q2 FY2025	6.5% – 7%	New
Aug 8, 2024	Adjusted EBIT margin	FY2025	6.5% – 7%	Raised
Aug 8, 2024	Total revenue	Q2 FY2025	$3.19B – $3.22B	New
Aug 8, 2024	Total revenue	FY2025	$12.74B – $13.02B	New
May 16, 2024	Non-GAAP Diluted EPS	Q1 FY2025	$0.55 – $0.60	New
May 16, 2024	Non-GAAP Diluted EPS	FY2025	$2.50 – $3.00	New
May 16, 2024	Free Cash Flow	FY2025	$400.00M	New
May 16, 2024	Adjusted EBIT Margin	Q1 FY2025	5.5% – 6%	New
May 16, 2024	Adjusted EBIT Margin	FY2025	6% – 7%	New
May 16, 2024	Organic Revenue Growth %	Q1 FY2025	-8% – -7%	New
May 16, 2024	Revenue $	Q1 FY2025	$3.10B – $3.15B	New
May 16, 2024	Organic Revenue Growth %	FY2025	-6% – -4%	New
May 16, 2024	Revenue $	FY2025	$12.67B – $12.95B	New
Feb 1, 2024	Non-GAAP Diluted EPS	Q4 FY2024	$0.80 – $0.85	New
Feb 1, 2024	non-GAAP diluted EPS	FY2024	$3.00 – $3.05	Lowered
Feb 1, 2024	free cash flow	FY2024	$800.00M	Reaffirmed
Feb 1, 2024	adjusted EBIT margin	FY2024	7.1% – 7.2%	Narrowed
Feb 1, 2024	Adjusted EBIT Margin	Q4 FY2024	7% – 7.5%	New
Feb 1, 2024	Revenue $	FY2024	$13.63B – $13.67B	Narrowed
Feb 1, 2024	Revenue $	Q4 FY2024	$3.35B – $3.39B	New
Feb 1, 2024	Organic Revenue Growth %	Q4 FY2024	-6.5% – -5.5%	New
Feb 1, 2024	organic revenue growth	FY2024	-4.5% – -4.3%	Lowered
Nov 1, 2023	Non-GAAP Diluted EPS	Q3 FY2024	$0.75 – $0.80	New
Nov 1, 2023	Non-GAAP Diluted EPS	FY2024	$3.15 – $3.40	Reaffirmed
Nov 1, 2023	Free Cash Flow	FY2024	$800.00M	Reaffirmed
Nov 1, 2023	Adjusted EBIT Margin	Q3 FY2024	7% – 7.5%	New
Nov 1, 2023	Adjusted EBIT Margin	FY2024	7% – 7.5%	Reaffirmed
Nov 1, 2023	Organic Revenue Growth %	Q3 FY2024	-5% – -4%	New
Nov 1, 2023	Revenue $	Q3 FY2024	$3.32B – $3.37B	New
Nov 1, 2023	Organic Revenue Growth %	FY2024	-4% – -3%	Reaffirmed
Nov 1, 2023	Revenue $	FY2024	$13.58B – $13.73B	Lowered
Aug 2, 2023	Non-GAAP Diluted EPS	Q2 FY2024	$0.65 – $0.70	New
Aug 2, 2023	Non-GAAP Diluted EPS	FY2024	$3.15 – $3.40	Lowered
Aug 2, 2023	Free Cash Flow	FY2024	$800.00M	Lowered
Aug 2, 2023	Adjusted EBIT Margin	FY2024	7% – 7.5%	Lowered
Aug 2, 2023	Adjusted EBIT Margin	Q2 FY2024	6.5% – 7%	New
Aug 2, 2023	Organic Revenue Growth %	FY2024	-4% – -3%	Lowered
Aug 2, 2023	Organic Revenue Growth %	Q2 FY2024	-5.5% – -4.5%	New
Aug 2, 2023	Revenue $	FY2024	$13.88B – $14.03B	Lowered
Aug 2, 2023	Revenue $	Q2 FY2024	$3.43B – $3.46B	New
May 18, 2023	Non-GAAP Diluted EPS	Q1 FY2024	$0.80 – $0.85	New
May 18, 2023	Non-GAAP Diluted EPS	FY2024	$3.80 – $4.05	Lowered
May 18, 2023	Free Cash Flow	FY2024	$900.00M	Lowered
May 18, 2023	Adjusted EBIT Margin	Q1 FY2024	7.5% – 8%	New
May 18, 2023	Adjusted EBIT Margin	FY2024	8% – 8.5%	Lowered
May 18, 2023	Organic Revenue Growth %	Q1 FY2024	-2% – -1%	New
May 18, 2023	Revenue	Q1 FY2024	$3.54B – $3.58B	New
May 18, 2023	Organic Revenue Growth %	FY2024	-0.5% – +0.5%	Lowered
May 18, 2023	Revenue	FY2024	$14.40B – $14.55B	New
Feb 1, 2023	Non-GAAP Diluted EPS	Q4 FY2023	$1.00 – $1.05	New
Feb 1, 2023	Non-GAAP Diluted EPS	FY2023	$3.45 – $3.50	Lowered
Feb 1, 2023	Free Cash Flow	FY2023	$630.00M	Narrowed
Feb 1, 2023	Adjusted EBIT Margin	Q4 FY2023	8.7% – 9.2%	New
Feb 1, 2023	Adjusted EBIT Margin	FY2023	8% – 8.1%	Lowered
Feb 1, 2023	Organic Revenue Growth %	Q4 FY2023	-3.1% – -2.6%	New
Feb 1, 2023	Revenue	Q4 FY2023	$3.62B – $3.64B	New
Feb 1, 2023	Organic Revenue Growth %	FY2023	-2.7% – -2.6%	Lowered
Feb 1, 2023	Revenue	FY2023	$14.46B – $14.47B	Narrowed
Nov 3, 2022	Non-GAAP Diluted EPS	Q3 FY2023	$0.80 – $0.85	New
Nov 3, 2022	Non-GAAP Diluted EPS	FY2023	$3.45 – $3.75	Reaffirmed
Nov 3, 2022	Non-GAAP diluted Earnings Per Share	FY2024	$5.00 – $5.25	Reaffirmed
Nov 3, 2022	Free Cash Flow	FY2023	$550.00M – $700.00M	Lowered
Nov 3, 2022	Free cash flow	FY2024	$1.50B	Reaffirmed
Nov 3, 2022	Adjusted EBIT Margin	Q3 FY2023	8% – 8.5%	New
Nov 3, 2022	Adjusted EBIT Margin	FY2023	8% – 8.5%	Reaffirmed
Nov 3, 2022	Adjusted EBIT margin	FY2024	10% – 11%	Reaffirmed
Nov 3, 2022	Restructuring and TSI	FY2024	$100.00M	Reaffirmed
Nov 3, 2022	Organic Revenue Growth %	Q3 FY2023	-2.5% – -1.5%	New
Nov 3, 2022	Revenue	Q3 FY2023	$3.55B – $3.58B	New
Nov 3, 2022	Organic Revenue Growth %	FY2023	-2% – -1%	Reaffirmed
Nov 3, 2022	Revenue	FY2023	$14.40B – $14.54B	Lowered
Nov 3, 2022	organic revenue growth	FY2024	+1% – +3%	Reaffirmed
Aug 3, 2022	Non-GAAP Diluted EPS	Q2 FY2023	$0.70 – $0.75	New
Aug 3, 2022	Non-GAAP Diluted EPS	FY2023	$3.45 – $3.75	Lowered
Aug 3, 2022	Non-GAAP diluted Earnings Per Share	FY2024	$5.00 – $5.25	Reaffirmed
Aug 3, 2022	Free Cash Flow	FY2023	$700.00M	Lowered
Aug 3, 2022	Free cash flow	FY2024	$1.50B	Reaffirmed
Aug 3, 2022	Adjusted EBIT Margin	Q2 FY2023	7% – 7.5%	New
Aug 3, 2022	Adjusted EBIT Margin	FY2023	8% – 8.5%	Lowered
Aug 3, 2022	Adjusted EBIT margin	FY2024	10% – 11%	Reaffirmed
Aug 3, 2022	Organic Revenue Growth %	Q2 FY2023	-2.5% – -1.5%	New
Aug 3, 2022	Revenue $	Q2 FY2023	$3.55B – $3.58B	New
Aug 3, 2022	Organic Revenue Growth %	FY2023	-2% – -1%	Reaffirmed
Aug 3, 2022	Revenue $	FY2023	$14.60B – $14.75B	Lowered
Aug 3, 2022	organic revenue growth	FY2024	+1% – +3%	Reaffirmed
May 25, 2022	Non-GAAP Diluted EPS	Q1 FY2023	$0.80 – $0.85	New
May 25, 2022	Non-GAAP Diluted EPS	FY2023	$3.85 – $4.15	New
May 25, 2022	Non-GAAP diluted Earnings Per Share	FY2024	$5.00 – $5.25	Reaffirmed
May 25, 2022	Free Cash Flow	FY2023	$800.00M	New
May 25, 2022	Free cash flow	FY2024	$1.50B	Reaffirmed
May 25, 2022	Adjusted EBIT Margin	Q1 FY2023	7.5% – 8%	New
May 25, 2022	Adjusted EBIT Margin	FY2023	8.5% – 9%	New
May 25, 2022	Adjusted EBIT margin	FY2024	10% – 11%	Reaffirmed
May 25, 2022	Organic Revenue Growth %	Q1 FY2023	-2.5% – -1.5%	New
May 25, 2022	Revenue $	Q1 FY2023	$3.70B – $3.75B	New
May 25, 2022	Organic Revenue Growth %	FY2023	-2% – -1%	New
May 25, 2022	Revenue $	FY2023	$14.90B – $15.05B	New
May 25, 2022	organic revenue growth	FY2024	+1% – +3%	Reaffirmed
Feb 2, 2022	Non-GAAP Diluted EPS	Q4 FY2022	$0.98 – $1.03	New
Feb 2, 2022	Non-GAAP Diluted EPS	FY2022	$3.64 – $3.69	Narrowed
Feb 2, 2022	Non-GAAP diluted EPS	FY2024	$5.00 – $5.25	Reaffirmed
Feb 2, 2022	Free Cash Flow	Q4 FY2022	$500.00M	New
Feb 2, 2022	Free Cash Flow	FY2022	$650.00M	Raised
Feb 2, 2022	Free cash flow	FY2024	$1.50B	Reaffirmed
Feb 2, 2022	Adjusted EBIT Margin	Q4 FY2022	8.7% – 9%	New
Feb 2, 2022	Adjusted EBIT Margin	FY2022	8.5% – 8.6%	Lowered
Feb 2, 2022	Adjusted EBIT margin	FY2024	10% – 11%	Reaffirmed
Feb 2, 2022	Non-GAAP Tax Rate	Q4 FY2022	26%	New
Feb 2, 2022	Net Interest Cost	Q4 FY2022	$25.00M	New
Feb 2, 2022	Non-GAAP Tax Rate	FY2022	25%	Lowered
Feb 2, 2022	Net Interest Cost	FY2022	$135.00M	Lowered
Feb 2, 2022	Restructuring and TSI	FY2022	$400.00M	Raised
Feb 2, 2022	Restructuring and TSI	FY2024	$100.00M	New
Feb 2, 2022	Organic Revenue Growth YoY	Q4 FY2022	-1.7% – -1.2%	New
Feb 2, 2022	Revenues	Q4 FY2022	$4.11B – $4.15B	New
Feb 2, 2022	Organic Revenue Growth YoY	FY2022	-2.3% – -2.2%	Lowered
Feb 2, 2022	Revenues	FY2022	$16.40B	Lowered
Feb 2, 2022	organic revenue growth	FY2024	+1% – +3%	Reaffirmed
Nov 3, 2021	Non-GAAP Diluted EPS	Q3 FY2022	$0.88 – $0.93	New
Nov 3, 2021	Non-GAAP Diluted EPS	FY2022	$3.52 – $3.72	New
Nov 3, 2021	Non-GAAP diluted EPS	FY2024	$5.00 – $5.25	New
Nov 3, 2021	Free Cash Flow	FY2022	$500.00M	New
Nov 3, 2021	Free cash flow	FY2024	$1.50B	New
Nov 3, 2021	Adjusted EBIT Margin	Q3 FY2022	8.6% – 8.9%	New
Nov 3, 2021	Adjusted EBIT Margin	FY2022	8.5% – 8.9%	New
Nov 3, 2021	Adjusted EBIT margin	FY2024	10% – 11%	New
Nov 3, 2021	Adjusted Effective Tax Rate	Q3 FY2022	28%	New
Nov 3, 2021	Net Interest Cost	Q3 FY2022	$33.00M	New
Nov 3, 2021	Adjusted Effective Tax Rate	FY2022	26%	New
Nov 3, 2021	Net Interest Cost	FY2022	$155.00M	New
Nov 3, 2021	Restructuring and TSI	FY2022	$550.00M	New
Nov 3, 2021	Restructuring and TSI	FY2024	$100.00M	New
Nov 3, 2021	Organic Revenue Growth YoY	Q3 FY2022	-2.5% – -1%	New
Nov 3, 2021	Revenues	Q3 FY2022	$4.08B – $4.13B	New
Nov 3, 2021	Organic Revenue Growth YoY	FY2022	-2% – -1%	New
Nov 3, 2021	Revenues	FY2022	$16.40B – $16.60B	New
Nov 3, 2021	organic revenue growth	FY2024	+1% – +3%	New

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases DXC Technology filed with the SEC as exhibits to Form 8-K or 6-K

Oct 29, 2026
DXC Technology Reports Second Quarter Fiscal Year 2027 Results
Results
Jul 30, 2026
DXC Announces Leadership Appointments to Accelerate Its AI-Centric Future
Update
Jul 30, 2026
DXC Technology Reports First Quarter Fiscal Year 2027 Results
Results
May 7, 2026
DXC Technology Reports Fourth Quarter and Full Fiscal Year 2026 Results
Results
Jan 29, 2026
DXC Technology Reports Third Quarter Fiscal Year 2026 Results
Results
Dec 9, 2025
DXC Technology Announces Redemption in Full and Delisting of 1.750% Senior Notes due 2026 and Partial Redemption of 1.800% Senior Notes due
Update
Dec 2, 2025
DXC Technology Prices Senior Notes Offering
News
Oct 30, 2025
DXC Technology Reports Second Quarter Fiscal Year 2026 Results
Results
Jul 31, 2025
DXC Technology Reports First Quarter Fiscal Year 2026 Results
Results
Jul 24, 2025
8-K exhibit EX-99.1
Update
May 14, 2025
DXC Technology Reports Fourth Quarter and Full Year Fiscal 2025 Results
Results
Feb 4, 2025
DXC Technology Reports Third Quarter Fiscal Year 2025 Results
Results
Nov 7, 2024
DXC Technology Reports Second Quarter Fiscal Year 2025 Results
Results
Aug 8, 2024
DXC Technology Reports First Quarter Fiscal Year 2025 Results
Results
May 16, 2024
DXC Technology Reports Fourth Quarter and Full Fiscal Year 2024 Results
Results
Mar 20, 2024
DXC Technology Adds Software and Technology Veteran Matt Fawcett to Senior Leadership Team
Update
Feb 1, 2024
DXC Technology Appoints Raul Fernandez as President and Chief Executive Officer
Update
Feb 1, 2024
DXC Technology Reports Third Quarter Fiscal Year 2024 Results
Results
Dec 20, 2023
DXC Technology Appoints Raul Fernandez as Interim President and CEO
Update
Nov 1, 2023
DXC Technology Reports Second Quarter Fiscal Year 2024 Results
Results
Aug 2, 2023
DXC Technology Reports First Quarter Fiscal Year 2024 Results
Results
May 18, 2023
DXC Technology Names Rob Del Bene Chief Financial Officer
Update
May 18, 2023
DXC Technology Reports Fourth Quarter and Full Fiscal Year 2023 Results
Results
Feb 1, 2023
DXC Technology Reports Third Quarter Fiscal Year 2023 Results
Results
Nov 3, 2022
DXC Technology Reports Second Quarter Fiscal Year 2023 Results
Results
Aug 3, 2022
DXC Technology Reports First Quarter Fiscal Year 2023 Results
Results
May 25, 2022
DXC Technology Reports Fourth Quarter Fiscal Year 2022 Results
Results
Feb 2, 2022
DXC Technology Reports Third Quarter Fiscal Year 2022 Results
Results
Nov 3, 2021
DXC Technology Reports Second Quarter Fiscal Year 2022 Results
Results
Mar 12, 2020
DXC Technology to Sell U.S. State and Local Health and Human Services Business to Veritas Capital for $5.0 Billion
Update
Mar 12, 2020
DXC Technology Provides Financial Update
Update
May 23, 2019
DXC Technology Delivers Strong Fourth Quarter Results with
Results
Aug 16, 2018
The Company has revised the following portions of the Fiscal 2018 10-K to reflect the retrospective revisions that have been made as a result of the reporting changes described above:
News
May 24, 2018
DXC Technology Delivers Fourth Quarter
Results
Aug 14, 2017
DXC Technology Prices Senior Floating Rates Notes Offering
News
Aug 14, 2017
DXC Technology Announces Results of 2017 Annual Meeting of Stockholders
News

Where these numbers come from

Parsed from the XBRL in DXC Technology's annual and quarterly filings with the SEC
Per-share figures adjusted for the 2-for-1 split on Mar 24, 1998
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is DXC.

Compare: DXC vs WDAY · DXC vs ADP · DXC vs KD · DXC vs INFY · DXC vs CTSH

Revenue growth-2.4% · median 5.7%

Gross margin23.0% · median 33.4%

Operating margin7.2% · median 13.2%

Net margin1.0% · median 12.3%

Company	Revenue	Growth
ADP	$22.26B	+6.5%
CTSH	$21.89B	+5.0%
KD	$14.97B	-0.6%
DXC	$12.48B	-2.4%
WDAY	$10.16B	+13.3%
INFY	–	–

Company

Next earnings (est.): Jan 28, 2027, during market hours
Exchange: NYSE
Industry: Services-Computer Processing & Data Preparation
Fiscal year ends: March 31
Employees: 115,000
Held by institutions: 100.0%
Auditor: Deloitte & Touche LLP
SEC CIK: 1688568

Advertisement
300 × 250